Botulinum toxin type A for treating upper or lower limb focal spasticity associated with stroke [ID768]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Cardiovascular risk assessment and lipid modificationStatus:In development | In consultationConsultation end date: 20 September 2024Expected publication date: 23 July 2025